The FDA has granted a Fast Track Designation to a new type of MRI contrast agent, ferumoxytol, which could be a safer alternative to gadolinium-based contrast agents for individuals with chronic kidney problems. Continued
News and Information about Personal Injury Lawsuits
Today's Date: Friday, November 21st, 2008
The FDA has granted a Fast Track Designation to a new type of MRI contrast agent, ferumoxytol, which could be a safer alternative to gadolinium-based contrast agents for individuals with chronic kidney problems. Continued